Plus   Neg

EMCOR Group Guides FY21 Above Estimates - Quick Facts

While reporting financial results for the fourth quarter on Thursday, EMCOR Group, Inc. (EME) initiated its earnings and revenue guidance for the full-year 2021, based on project mix, visibility into the coming year, and assuming a gradual improvement of current market conditions as the year progresses.

For fiscal 2021, the company now projects earnings in a range of $6.20 to $6.70 per share on revenues between $9.2 billion to $9.4 billion.

On average, analysts polled by Thomson Reuters expect the company to report earnings of $5.77 per share on revenues of $8.83 billion for the year. Analysts' estimates typically exclude special items.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Johnson & Johnson's (JNJ) Covid-19 vaccine is expected to be back on track as early as this weekend as a decision is expected after the advisory panel meeting of the U.S. Centers for Disease Control and Prevention (CDC) slated on April 23, according to Dr. Anthony Fauci, the chief medical adviser to President Joe Biden. MK-4482, the experimental antiviral drug for COVID-19, showed promise to prevent and treat SARS-CoV-2 infection in hamster study, according to the scientists of National Institutes of Health or NIH. The drug significantly decreased levels of virus and disease damage in the lungs of hamsters treated for SARS-CoV-2 infection. MK-4482, delivered orally, is now in Phase 2 and 3 human clinical studies. Beverages giant Coca-Cola reported a 19 percent decline in profit for the second quarter from last year as a revenue growth of 5 percent and improved margins were offset by higher income taxes and interest expense. However, adjusted earnings per share and revenues topped analysts' expectations. The company also maintained its adjusted earnings and organic revenue growth outlook for fiscal 2021.
Follow RTT